Prevents rejection in renal homotransplantation. ANDA 75252, held by Aaipharma LLC. Azathioprine.
As of Nov 16, 2026, ANDA 75252 (Azasan), held by Aaipharma LLC, was first approved by FDA on Jun 7, 1999, with 19 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE: Azathioprine Tablets are indicated as an adjunct for the prevention of rejection in renal homotransplantation. It is also indicated for the management of active rheumatoid arthritis to reduce signs and symptoms. Renal Homotransplantation: Azathioprine Tablets are
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 7, 1999 | Original application | Approved |
| Azasan50MG · tablet;oral | Azathioprine | Rx |
| Azasan25MG · tablet;oral | Azathioprine | Rx |
| Azasan75MG · tablet;oral | Azathioprine | Rx |
| Azasan100MG · tablet;oral | Azathioprine | Rx |
| May 7, 2025 | Supplement 27Labeling · Standard review | Approved | None posted |
| May 7, 2025 | Supplement 26Labeling · Standard review | Approved | None posted |
| Nov 28, 2023 | Supplement 23Labeling · Standard review | Approved | None posted |
| Jan 11, 2022 | Supplement 21Labeling · Standard review | Approved | None posted |
| Sep 2, 2015 | Supplement 18Labeling · Standard review | Approved | None posted |
| Sep 2, 2015 | Supplement 17Labeling | Approved | None posted |
| Sep 13, 2006 | Supplement 15Labeling | Approved | None posted |
| Mar 2, 2006 | Supplement 14Labeling | Approved | None posted |
| Feb 3, 2003 | Supplement 11Labeling | Approved | None posted |
| Feb 3, 2003 | Supplement 10Manufacturing | Approved | None posted |
| Feb 3, 2003 | Supplement 9Manufacturing | Approved | None posted |
| Feb 3, 2003 | Supplement 8Labeling | Approved | None posted |
| Feb 3, 2003 | Supplement 7Manufacturing | Approved | None posted |
| Feb 3, 2003 | Supplement 6Manufacturing | Approved | None posted |
| Feb 3, 2003 | Supplement 5Manufacturing | Approved | None posted |
| Aug 14, 2002 | Supplement 4Manufacturing | Approved | None posted |
| Jul 18, 2001 | Supplement 3Labeling | Approved | None posted |
| Jul 18, 2001 | Supplement 2Manufacturing | Approved | None posted |
| Nov 20, 2000 | Supplement 1Manufacturing | Approved | None posted |
| Jun 7, 1999 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters